Ebeling K, Bilek K
Zentralbl Gynakol. 1978;100(14):897-912.
Trophoblastic tumors are among the rare diseases in this country. The most important clinical aspects are demonstrated by references and personal experiences in the treatment of trophoblastic tumors. In many countries (SU, USA, GB, Japan) the treatment of trophoblastic tumors has been centralized.--The therapeutical strategy is based on histology, stage and other important prognostic factors. Most important is chemotherapy with antineoplastic substances. Surgery and radiation are to be used only under appropriate indication. After treatment the control of the HCG-values by radioimmunassay is of high importance for the early diagnosis of relapse.--All facts demonstrate, that also in the GDR a stronger centralization of the treatment of trophoblastic tumors should be attained.
滋养细胞肿瘤在该国属于罕见疾病。参考文献以及个人在滋养细胞肿瘤治疗方面的经验展示了其最重要的临床方面。在许多国家（苏联、美国、英国、日本），滋养细胞肿瘤的治疗已实现集中化。治疗策略基于组织学、分期及其他重要的预后因素。最重要的是使用抗肿瘤药物进行化疗。仅在适当指征下才使用手术和放疗。治疗后，通过放射免疫测定法监测血绒毛膜促性腺激素（HCG）值对于复发的早期诊断至关重要。所有事实表明，在民主德国（东德）也应实现更强有力的滋养细胞肿瘤治疗集中化。
